Disease/Infection News

RSS

HIV stigma: an interview with Dr. Vargas-Jackson, M.D. Howard University Hospital

Stigma has been defined as a social opportunistic disease that attaches to many illnesses and increases morbidity and mortality rates. Stigma is the shame or disgrace attached to illnesses and diseases regarded as socially unacceptable.

11 Dec 2013

Results-Based Financing for Health can get 20% more health care with same funds

Countries and major donors are changing the way they finance maternal and child, malaria, tuberculosis and HIV/AIDS health programs in low-income countries to increase their impact.

11 Dec 2013

Detectable blood viral load increases prevalence of heart disease

HIV causes structural heart disease according to research presented at EuroEcho-Imaging 2013 by Dr Nieves Montoro from Madrid, Spain. The findings support the introduction of cardiovascular screening in all HIV patients, particularly those with a positive blood viral load.

11 Dec 2013

New antimicrobial coating prevents infections during cold winter months

With cold and flu season now in full swing, all-natural wellness provider Neutra Corp. (OTCBB: NTRR) is working quickly to deliver a revolutionary new antimicrobial coating that could soon prove to be the best defense against infections and viruses in the most notorious hotspot for the spread of these diseases: the classroom.

11 Dec 2013

New AquaLyse ionization technology prevents legionella and related disease outbreaks

With growing reports of Legionella and related Legionnaires' disease outbreaks in the USA, Canada and around the world, ProCare Water Treatment Inc. today announces its newest "AquaLyse® ICR-820" medical and commercial grade copper-silver ionization chamber cells.

11 Dec 2013

Duke University receives $2.9M grant to develop HIV vaccine candidate

Duke University has received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to produce an HIV vaccine candidate that will be tested in humans.

10 Dec 2013

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

UHC announced its selection as a coordinating entity for a 3-year, $7.3 million contract from the Agency for Healthcare Research and Quality that has been awarded to the Johns Hopkins Armstrong Institute for Patient Safety and Quality to reduce ventilator-associated pneumonia in hospitals.

10 Dec 2013

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

In Zambia, the incidence of all forms of human tuberculosis is estimated to be 444 per 100,000. There is also a high incidence of HIV and AIDS in the country. In the Kafue area, a high incidence of Mycobacterium bovis in both cattle and the Kafue lechwe antilope has been detected. This bacterium can infect humans and has been found in humans in the studied region of Namwala. Mycobacterium tuberculosis, which is the main cause of human tuberculosis, has also been detected in cattle in this region.

10 Dec 2013

Preparing for better management of Tamiflu-resistant influenza viruses

Researchers in Umeå and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious consequences in the event of an influenza pandemic. With more than 14 million SEK from the Swedish Research Councils Formas and VR, the research team will now continue their studies with a focus on alternative antiviral drugs.

10 Dec 2013

Restricting antibiotics use unlikely to stop spread of drug resistance in typhoid fever

Restricting the use of antibiotics is unlikely to stop the spread of drug resistance in typhoid fever, according to a study funded by the Wellcome Trust and published in the journal eLife.

10 Dec 2013

Study reveals that germ-free mice are susceptible to infection with foodborne pathogen

When it comes to fighting off pathogens like Listeria, your best allies may be the billions of microorganisms that line your gut, according to new research published in mBio-, the online open-access journal of the American Society for Microbiology.

10 Dec 2013

Arrowhead reports Phase 1 study data on ARC-520 for treatment of chronic hepatitis B infection

Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.

9 Dec 2013

MUC5B protein plays key role in many lung-related ailments

An international team of researchers has zeroed in on a protein that plays a key role in many lung-related ailments, from seasonal coughing and hacking to more serious diseases such as MRSA infections and cystic fibrosis.

9 Dec 2013

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Untreated, the mortality probably exceeds 70%. Flesh eating is a description of Toxic Inflammatory Cellulitis which usually starts by bacterial subcutaneous infection followed by freezing in phase II healing which is inflammatory.

9 Dec 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.

9 Dec 2013

Malaria cases in the U.S. rising due to international travel, inadequate use of prevention methods

The number of malaria cases in the United States is rising, a trend that can be linked to the increasing amount of international travel and inadequate use of prevention methods.

9 Dec 2013

Revised Clinical Practice Guidelines on management of HCV published by EASL

The European Association for the Study of the Liver today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection. The EASL guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV.

9 Dec 2013

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

8 Dec 2013

ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in China causing severe respiratory illness.

6 Dec 2013

Imported measles poses a threat to health security

Experts report that measles still poses a threat to public health in the U.S, despite vaccination having successfully eliminated the endemic since the 1960s.

6 Dec 2013

Disease/Infection News

HIV stigma: an interview with Dr. Vargas-Jackson, M.D. Howard University Hospital

Results-Based Financing for Health can get 20% more health care with same funds

Detectable blood viral load increases prevalence of heart disease

New antimicrobial coating prevents infections during cold winter months

New AquaLyse ionization technology prevents legionella and related disease outbreaks

Duke University receives $2.9M grant to develop HIV vaccine candidate

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

Preparing for better management of Tamiflu-resistant influenza viruses

Restricting antibiotics use unlikely to stop spread of drug resistance in typhoid fever

Study reveals that germ-free mice are susceptible to infection with foodborne pathogen

Arrowhead reports Phase 1 study data on ARC-520 for treatment of chronic hepatitis B infection

MUC5B protein plays key role in many lung-related ailments

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Malaria cases in the U.S. rising due to international travel, inadequate use of prevention methods

Revised Clinical Practice Guidelines on management of HCV published by EASL

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

Imported measles poses a threat to health security

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News